Endocrinology Fellowship Leadership
About Our Advanced Endocrinology Training Leaders
Partha S. Sinha, MD, PhD
Program Director, Endocrinology, Diabetes & Metabolism Fellowship
Instructor in Medicine, Harvard Medical School
Dr. Partha S. Sinha has been a member of the Division of Endocrinology, Diabetes and Metabolism at Beth Israel Deaconess Medical Center since 2017. He is a summa cum laude graduate of the University of Pennsylvania. He is a graduate Tufts University Medical School. He also received a PhD at Tufts University Graduate School with his thesis focusing on neuroendocrine control of temperature. He served as an intern and resident in Medicine at Beth Israel Deaconess Medical Center and completed a fellowship in Endocrinology at Massachusetts General Hospital. He is a clinician educator, focusing on metabolic bone disease and calcium homeostasis as well as adrenal disorders and is Program Director for the BIDMC/JDC Joint Endocrinology Fellowship Training Program.
Maria Vamvini, MD
Associate Program Director, Endocrinology, Diabetes & Metabolism Fellowship
Instructor in Medicine, Harvard Medical School
Dr. Maria Vamvini is a Staff Physician at Joslin Diabetes Center and Instructor in Medicine at Harvard Medical School. Dr. Vamvini earned her medical degree from Aristotle University of Thessaloniki in Greece. She completed her residency in internal medicine at Mount Auburn Hospital in Cambridge, MA. Following her residency, she served as Chief Medical Resident and completed a one-year fellowship in medical education at the same institution. Subsequently, she completed her fellowship in Endocrinology, Diabetes, and Metabolism at the joint Beth Israel Deaconess Medical Center and Joslin Diabetes Center fellowship program. Dr. Vamvini currently sees patients in the Adult Diabetes Clinic at Joslin and the Endocrinology Clinic at Beth Israel Deaconess Medical Center. She is triple board certified in Internal Medicine, Endocrinology, and Obesity Medicine.
Dr. Vamvini’s primary research focus is to investigate how physical activity counteracts the detrimental effects of obesity and enhances overall health, both in mouse models of metabolic disease and in human subjects. She utilizes cutting-edge omics platforms, including single-cell transcriptomics, to analyze various tissues and elucidate the mechanisms underlying these effects.